Fewer Patients With Diabetes Meeting Treatment Targets
Target achievement was lower among younger patients, particularly those under age 40 years.
Stay updated with breaking news from Lawrence Leiter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Target achievement was lower among younger patients, particularly those under age 40 years.
May 14, 2021 For patients with type 2 diabetes and stable coronary disease who have not had an MI or stroke, specific factors related to their diabetes should not necessarily come into play when physicians are deciding whether they should add ticagrelor (Brilinta; AstraZeneca) to the treatment regimen, a post hoc analysis of the THEMIS and THEMIS-PCI studies indicates. Nor did they influence the trial findings, investigators say. The complex balance between efficacy and safety demonstrated in the overall trial cohort as well as in the subset with a history of PCI was not significantly influen...